CLINICAL TRIALS PROFILE FOR CHEMET
✉ Email this page to a colleague
All Clinical Trials for CHEMET
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT03630991 ↗ | Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy | Recruiting | National Cancer Institute (NCI) | Phase 1 | 2018-10-11 | This phase I trial studies the side effects and best dose of edetate calcium disodium or succimer in treating patients with acute myeloid leukemia or myelodysplastic syndrome undergoing chemotherapy. Edetate calcium disodium or succimer may help to lower the level of metals found in the bone marrow and blood and may help to control the disease and/or improve response to chemotherapy. |
NCT03630991 ↗ | Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy | Recruiting | M.D. Anderson Cancer Center | Phase 1 | 2018-10-11 | This phase I trial studies the side effects and best dose of edetate calcium disodium or succimer in treating patients with acute myeloid leukemia or myelodysplastic syndrome undergoing chemotherapy. Edetate calcium disodium or succimer may help to lower the level of metals found in the bone marrow and blood and may help to control the disease and/or improve response to chemotherapy. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for CHEMET
Condition Name
Condition Name for CHEMET | |
Intervention | Trials |
Myelodysplastic Syndrome | 1 |
Secondary Myelodysplastic Syndrome | 1 |
Myelodysplastic/Myeloproliferative Neoplasm | 1 |
Very High Risk Myelodysplastic Syndrome | 1 |
[disabled in preview] | 0 |
This preview shows a limited data set Subscribe for full access, or try a Trial |
Clinical Trial Locations for CHEMET
Trials by Country
Clinical Trial Progress for CHEMET
Clinical Trial Phase
Clinical Trial Sponsors for CHEMET
Sponsor Name